Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2206240
Max Phase: Preclinical
Molecular Formula: C20H25F3N6O
Molecular Weight: 422.46
Molecule Type: Small molecule
Associated Items:
ID: ALA2206240
Max Phase: Preclinical
Molecular Formula: C20H25F3N6O
Molecular Weight: 422.46
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC[C@H](CO)Nc1nc(NCc2cccc(C(F)(F)F)c2)c2ncn(C(C)C)c2n1
Standard InChI: InChI=1S/C20H25F3N6O/c1-4-15(10-30)26-19-27-17(16-18(28-19)29(11-25-16)12(2)3)24-9-13-6-5-7-14(8-13)20(21,22)23/h5-8,11-12,15,30H,4,9-10H2,1-3H3,(H2,24,26,27,28)/t15-/m1/s1
Standard InChI Key: QXGDDAJYIXAKAM-OAHLLOKOSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 422.46 | Molecular Weight (Monoisotopic): 422.2042 | AlogP: 4.22 | #Rotatable Bonds: 8 |
Polar Surface Area: 87.89 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 3 |
#RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 5.20 | CX LogP: 3.77 | CX LogD: 3.77 |
Aromatic Rings: 3 | Heavy Atoms: 30 | QED Weighted: 0.50 | Np Likeness Score: -1.09 |
1. Liang M, Tarr TB, Bravo-Altamirano K, Valdomir G, Rensch G, Swanson L, DeStefino NR, Mazzarisi CM, Olszewski RA, Wilson GM, Meriney SD, Wipf P.. (2012) Synthesis and biological evaluation of a selective N- and p/q-type calcium channel agonist., 3 (12): [PMID:24936234] [10.1021/ml3002083] |
2. Lee JW, Hirota T, Ono D, Honma S, Honma KI, Park K, Kay SA.. (2019) Chemical Control of Mammalian Circadian Behavior through Dual Inhibition of Casein Kinase Iα and δ., 62 (4): [PMID:30707835] [10.1021/acs.jmedchem.8b01541] |
Source(1):